|
|
||||||||
J Thorac Cardiovasc Surg 1998;115:178-189
© 1998 Mosby, Inc.
CARDIOPULMONARY SUPPORT AND PHYSIOLOGY |
From the Department of Cardio-Thoracic Surgery, Harefield Hospital, Harefield, Middlesex, London, United Kingdom.
Received for publication Jan. 27, 1997; revisions requested March 11, 1997; revisions received July 31, 1997; accepted for publication July 31, 1997. Address for reprints: R. Mazhar, FRCS, Department of Cardio-Thoracic Surgery, Harefield Hospital, Harefield, Middlesex, UB9 6JH, London, United Kingdom.
Abstract
Objective: We report a clinical study on the use of 7.2%, 2400 mOsm/L, hypertonic saline solution compared with gelatin in early postoperative period after coronary artery bypass surgery.
Methods: Two groups (n = 10 each) received 5 ml/kg of either saline solution or gelatin over 1 hour. Cardiac index, central venous pressure, pulmonary capillary wedge pressure, systemic and pulmonary vascular resistance indices, arterial oxygen tension, plasma osmolarity, electrolytes, and urinary output were recorded before starting the infusion and subsequently at 10, 30, 60, 90, 120, 240 and 600 minutes. Plasma creatinine, urea, electrolytes, urinary volume, and sodium excretion were measured at 12 and 24 hours.
Results: There were no significant demographic or operative differences between the groups. Patients receiving saline solution had a larger diuresis at 12 (p = 0.0008) and 24 hours (p = 0.002), with less positive balance at 12 hours (p = 0.0008). The group receiving saline solution had better cardiorespiratory recovery with shorter extubation time (p = 0.033), and earlier increase in cardiac index with a positive correlation between plasma sodium content and cardiac index. Maximum increase in cardiac index (+31%) occurred at 60 minutes (p = 0.025) associated with 8% increase in plasma sodium content (r = 0.51, p = 0.01), without a concomitant rise in pulmonary capillary wedge pressure. The group receiving gelatin had a linear increase in cardiac index with increasing pulmonary capillary wedge pressure, reaching +16% from baseline by 90 minutes. Compared with the gelatin-treated group, patients receiving saline solution had unchanged systemic vascular resistance index but a significantly lower pulmonary vascular resistance index with a negative correlation to plasma sodium content. There was no difference in levels of urea and creatinine. No side-effect attributable to the use of saline solution was observed.
Cardiopulmonary bypass (CPB) is known to produce fluid retention
1 and disturbed microcirculation
2 along with depressed cardiorespiratory state for a variable period after the operation. The exact cause or the changes leading to this state are unclear.
We have conducted this study with the hypothesis that during the protracted hypotensive state of CPB, significant endothelial and visceral edema ensues, subsequent to the breakdown of energy-dependent volume-regulatory mechanisms, contributing to multiorgan dysfunction. Increasing plasma osmolarity with an electrolyte solution (hypertonic saline solution, HTS) that would not avidly cross into the intracellular compartment can be expected to osmotically reverse this presumed intracellular fluid retention and hence generally improve endothelial, myocardial, and other visceral function.
Experimental use of hyperosmolar saline solutions is not new. In 1919, Penfield
3 described the use of 2% sodium bicarbonate in hypovolemic dogs. In 1973, Moylan, Reckler, and Mason
4 reported the usefulness of 1.8% saline solution in the treatment of patients with shock caused by burns. In 1980, De Flippe and coworkers,
5 using 7.5% HTS, successfully treated nine of 12 patients with severe hypovolemic shock of varied causes. Since these reports, interest has been renewed in "small volume resuscitation" using hyperosmolar salt solutions in the treatment of trauma,
6 during aortic operations,
7 during cardiogenic shock,
8 and during cardiac anesthesia.
9 Most of these studies used a mixture of HTS with a synthetic colloid (dextran or hydroxyethyl starch). Observations made on infusion of a mixture of two synergistically active ingredients may have blurred the effects of HTS alone.
Cross and associates
10 have gainfully used weak HTS (1.8%), comparing it with 0.9% saline solution, after coronary artery bypass grafting (CABG). However, the condition of their subjects was hemodynamically stabilized by means of synthetic colloids and blood products before the HTS solution was administered. The role of HTS alone in the early post-CABG period has not been studied. For the present study we have used 7.2% HTS, because when the concentration is above 7.5% not only does hemolysis occur but the hemodynamic effects plateau as well.
11
GEL (gelatin; Haemaccel, Hoechst-Roussel Pharm, Inc., Somerville, N.J.) is the standard primary volume expander at our institution; hence it was used as the control.
Patients and methods
Design: Prospective, randomized, double-blind trial.
The study was approved by the hospital ethical committee and informed consent was obtained form all patients.
Subjects.
The study comprised 20 adult patients undergoing elective CABG. Exclusion criteria were age older than 75 years, preoperative ejection fraction less than 35%, plasma creatinine content greater than 135 µmol/L, preoperative angiotensin-converting enzyme inhibitors, need for inotropic support, and postoperative bleeding more than 200 ml/hr or necessitating resternotomy for hemostasis. During the period of the study, all randomly contacted patients except one consented to participate in the study. There were no postoperative exclusions.
Methods
Anesthesia and surgery. All operations (CABG) were performed by a single surgical and anesthetic team. A thermodilution catheter was inserted before the operation in all patients. CPB was instituted with a nonpulsatile pump (Medtronic Bio-Medicus, Eden Prairie, Minn.) and an Avecor affinity membrane oxygenator (Avecor Cardiovascular, Inc., Plymouth, Minn.). The myocardium was protected by the use of systemic hypothermia to 28° C, topical ice slush, and intermittent, antegrade, crystalloid cardioplegia with St. Thomas' Hospital solution (15 ml/kg) repeated every 30 minutes at 7 ml/kg. Pump prime consisted of Hartmann's solution 500 ml, GEL 500 ml, 20% mannitol 150 ml, and heparin 5000 units given intravenously. Additional Hartmann's solution was used to maintain the reservoir volume at a minimum of 500 ml. Packed red cells were transfused if the hemoglobin value was less than 8 gm/dl.
Postoperative fluids. In the intensive treatment unit 4% dextrose/0.18% saline solution with 20 mmol K, at a rate of 1 ml/kg, was given as maintenance fluid. Patients were assigned to receive 5 ml/kg of either 7.2% HTS (2400 mOsm/L, Na+ and Cl- 1200 mEq/L each) or GEL (Polygeline [degraded and modified gelatin, average molecular weight 30,000] 35 gm, Na+ and Cl- content 145 mEq/L each, Ca++ 6.25 mmol/L, osmolarity 301 mOsm/L) over 1 hour. The fluid was prepared by the pharmacy department, and the investigators were blinded to the solution in use. Additional fluid infusion was administered by the intensive training unit nurse caring for the patient if the central venous pressure or pulmonary capillary wedge pressure fell to 5 mm Hg or if the blood pressure was below 80/50 mm Hg. The identity code of the solution was broken at the completion of the study. GEL or packed red cells, or both (if the hemoglobin value was less than 9 gm/L), were administered to maintain these values.
Ventilation/extubation. Postoperative ventilation was adjusted to maintain arterial oxygen tension greater than 12 kPa, carbon dioxide tension 4.5 to 5 kPa, and pH greater than 7.32. Patients were extubated according to the following criteria: awake, respiratory rate less than 30 breaths/min, inspired oxygen fraction less than 0.5, arterial oxygen tension more than 10 kPa, tidal volume greater than 5 ml/kg, arterial carbon dioxide tension less than 5.5 kPa, minimal bleeding (<50 ml/hr), and axillary temperature greater than 36.5° C.
Fluid balance. Intraoperative fluid balance was calculated as follows: (fluids infused [crystalloid + colloid] + pump prime + cardioplegia + blood) - (diuresis + volume left in the pump + volume in the suction's reservoir). Insensible losses were not accounted for in either group.
Measurements and monitoring.Measurements were made before the start of HTS or GEL infusion (baseline) and at 10, 30, 60 (end of infusion), 90, 120, 240, 400, and 600 minutes afterward. At each point, the following three groups of parameters were noted:
Urinary output and sodium excretion at 12 and 24 hours were recorded.
Statistics.
The data were analyzed with the use of SPSS for Windows (version 6) (SPSS, Inc., Chicago, Ill.) and Microsoft Excel software package (Microsoft Corporation, Redmond, Wash.). For parameters with multiple measurements, two-way analysis of variance was used to simultaneously evaluate the effects of time and group. The Spearman test was used for correlation of the parameters at different time points. Nonserial observations were compared by means of the Wilcoxon-Mann-Whitney test. Significance was taken at p< 0.05. Of the measured parameters, SVRI and CI were found to be significantly different in the two groups at their baseline values. Hence these were compared after the raw data had been transformed into values depicting change from their baseline levels. For example, change in CI at a time point (t) = CI (0) [minus] CI (t), where CI (0) is the baseline value.
Results
The two groups did not differ with regard to the anesthetic, CPB, and operative techniques. Although the GEL group included three women whereas the HTS group was all male, no significant group differences were identified between age, weight, body surface area, preoperative left ventricular ejection fraction, and intraoperative fluid balance (Table I).
|
|
|
The urinary output at 24 hours remained high for the HTS group (66.4 ± 7 ml/kg vs 39 ± 3.3 ml/kg; p= 0.0029). This diuresis did not affect either plasma K level or further K requirement. In fact, plasma K levels generally remained higher, but within normal limits, in the HTS group. No tachyarrhythmia occurred in either group. Only a single dose of 20 mg furosemide was given to one of the patients in the GEL group.
Plasma Na content and osmolarity were significantly higher in the HTS group. Maximum Na level in the HTS was 156.9 mEq/L at 60 minutes. At 12 hours, plasma Na was significantly higher in the HTS group (p= 0.0003), but by 24 hours there was no difference between the two groups (p= 0.19).
Urinary excretion of sodium continued to remain significantly higher in the HTS group until the 24-hour measurements. No significant difference was noted between the plasma creatinine or urea levels of the two groups at either 12 or 24 hours (Table III).
|
No decrease in the calculated SVRI was noted in the HTS group of patients. It remained within 3 to +9% of the baseline mean value for the whole observation period. On the contrary, patients in the GEL group had a gradual fall in SVRI, reaching 72% of the baseline mean by 10 hours (p= 0.009, Fig. 2). In contrast, the GEL group had +9% to +20% higher PVRI at most time points before reaching the baseline mean value at 10 hours. In the HTS group, however, PVRI was significantly lower at 30 minutes (p= 0.019), 60 minutes (p= 0.039), 120 minutes (p= 0.019), and at 4 hours (p= 0.0059). Peculiarly, no difference was observed at 90 minutes (p= 0.089) (Fig. 3). PVRI in the HTS group had a negative correlation with plasma Na and osmolarity at 30 minutes (p= 0.029, p= 0.5), 120 minutes (p= 0.039, p= 0.4), and at 4 hours (p= 0.0039, p= 0.6).
|
|
|
|
|
|
Discussion
The results of this study are in contrast to the conventional wisdom of the therapy of the failing heart. It may be that the nostrum of avoiding administration of extra sodium in this circumstance is incorrect. In the present study, although the two groups had similar fluid retention during the operation, 12 hours after the operation the mean net fluid balance in the HTS group was less by 33.5 ml/kg (+29.57 ml/kg vs +63.08 ml/kg for GEL, p= 0.007). This difference was mainly due to the extra diuresis in the HTS patients (p= 0.00089), rather than significantly different amounts of postoperative fluid infusion (p= 0.29). This "diuresis without additional fluid requirement" was associated with improved hemodynamics and respiratory function. Does this represent a correction of the intracellular fluid retention that may occur during CPB?
Fluid retention with CPB is estimated to be 800 ml/m2 per hour of CPB time.
12 Customarily, this extra fluid is regarded to be sequestered mainly in the interstitial part of the extracellular fluid compartment.
13 Variations in the intracellular water after CPB and its implication on cardiorespiratory function are not known. Direct measurement of intracellular water is difficult; measurements are derived by subtracting extracellular fluid volume from total body water. However the isotopes most commonly used for estimation of extracellular fluid volume, Br82 and S35, do penetrate the cells. Breckenridge, Digerness, and Kirklin,
13 using inulin, which does not cross into the cells, have found a smaller increase in the Br82 space as compared with inulin space (+18.6% vs +33%). This observation highlights the uncertainty regarding measurement of the exact amount of the fluid retained in different body compartments after CPB.
On the other hand, there is evidence to suggest that CPB may increase intracellular water content. Generalized capillary endothelial swelling has been documented after CPB.
14 Similarly, intracellular fluid retention is noted to occur during protracted low perfusion, situations that essentially mimic a CPB state (for example, hemorrhagic shock
15) and after major operations.
16
If a significant increase in intracellular water content with visceral and endothelial edema contributes to postoperative multiorgan dysfunction, then the choice of volume replacement fluid may be very important. A medium would be desirable that can translocate volume from intracellular fluid and the extracellular fluid and encourage its excretion. In this regard, HTS and colloids differ in their target area for mobilization of fluid.
Colloids move water from the interstitium into the intravascular compartment, whereas HTS shifts water out of the intracellular compartment.
17 The reason is that the cell membrane restricts free movement of electrolytes whereas the capillary endothelium is freely permeable to Na and Cl.
18 Along with this fluid shift, direct renal vasodilatation and increased glomerular filtration rate seen with HTS
19 should make it more useful in the post-CPB period.
HTS has a threefold to sevenfold plasma volume expansion effect as compared with a 1:1 effect of the synthetic colloids. Besides, the speed with which HTS expands plasma volume is almost five and ten times faster than that of synthetic colloids and isotonic saline solution, respectively.
18,20
HTS infusion produces a sudden increase in the plasma osmolarity, which leads to quick efflux of fluid, first out of the cells that are contiguous with the plasma (that is, red blood cells and the capillary endothelium) and then from the interstitium. Capillary endothelium is freely permeable to Na and Cl, and within 30 minutes the interstitial space establishes sodium equilibration with the plasma.
18 Unlike capillary endothelium, the tissue cells restrict free movement of electrolytes and hence steadily give up water as the interstitial sodium concentration rises. By the time extracellular fluid comes into new salt equilibrium, it is estimated that the intracellular fluid has a net volume deficit of approximately 3% to 6%, which is gained by plasma and the interstitial space in almost equal ratios.
18,21 Such osmotic translocation of intracellular water is noted to improve cardiac compliance.
18 Besides, there are reports that HTS has a direct inotropic effect on myocardium
22 and improves microcirculatory flow as a result of hemodilution, decreased capillary hydraulic resistance, and improved red blood cell rheology.
23
In summary, the patients receiving HTS were extubated significantly earlier than those receiving conventional fluid replacement with a synthetic colloid. A decrease in the need for inotropic drugs and a decrease in PVRI were also noted. These data may support the hypothesis that generalized intracellular edema contributes to post-CPB multiorgan dysfunction and that there is therefore a role for HTS in counteracting this complication.
A larger sample, with measurement of intracellular water content, would be required to validate this hypothesis. From these preliminary data, however, it would be tempting to observe the cardiopulmonary effects of hypernatremic hyperosmolarity if it is maintained at or above 8% by continuous infusion of HTS.
We believe that HTS has a beneficial role to play in CPB-based procedures. Its use as an addition to pump prime, postoperative fluid replacement, and in situations of multiorgan dysfunction after CPB need further evaluation.
|
|
|
|
This article has been cited by other articles:
![]() |
R. Bueno, A. C. Resende, R. Melo, V. A. Neto, and N. A. G. Stolf Effects of hypertonic saline-dextran solution in cardiac valve surgery with cardiopulmonary bypass Ann. Thorac. Surg., February 1, 2004; 77(2): 604 - 611. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |